-+ 0.00%
-+ 0.00%
-+ 0.00%

Jaguar Health completes FDA submission seeking full approval of Canalevia-CA1 for dog chemo diarrhea

PUBT·06/23/2026 13:01:08
Listen to the news
Jaguar Health completes FDA submission seeking full approval of Canalevia-CA1 for dog chemo diarrhea
  • Jaguar Health completed submission of a New Animal Drug Application to the FDA’s Center for Veterinary Medicine for full approval of crofelemer in chemotherapy-induced diarrhea in dogs.
  • Crofelemer, sold as Canalevia-CA1, currently holds conditional approval for the indication.
  • Submission includes a pivotal effectiveness study showing statistically significant results, with 77% of owners reporting the treatment was effective.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606230900ACCESSWRNAPR_____1180236) on June 23, 2026, and is solely responsible for the information contained therein.